Biomedical Engineering Reference
In-Depth Information
43. Lloyd TE, Atkinson R, Wu MN, Zhou Y, Pennetta G, Bellen HJ. 2002. Hrs regulates en-
dosome membrane invagination and tyrosine kinase receptor signaling in
Drosophila
.
Cell
108
(2):261-269.
44. Entchev EV, Gonzalez-Gaitan MA. 2002. Morphogen gradient formation and vesicular traf-
ficking.
Traffic
3
(2):98-109.
45. Peri F, Bokel C, Roth S. 1999. Local
gurken
signaling and dynamic MAPK activation during
Drosophila
oogenesis.
Mech Dev
81
(1-2):75-88.
46. Sapir A, Schweitzer R, Shilo BZ. 1998. Sequential activation of the EGF receptor pathway
during
Drosophila
oogenesis establishes the dorsoventral axis.
Development
125
(2):191-200.
47. Hsu T, McRackan D, Vincent TS, Gert de Couet H. 2001.
Drosophila
Pin1 prolyl isomerase
Dodo is a MAP kinase signal responder during oogenesis.
Nature Cell Biol
3
(6):538-543.
48. Mantrova EY, Hsu T. 1998. Down-regulation of transcription factor CF2 by Drosophila
Ras/MAP kinase signaling in oogenesis: cytoplasmic retention and degradation.
Genes Dev
12
(8):1166-1175.
49. Sturtevant MA, Roark M, O'Neill JW, Biehs B, Colley N, Bier E. 1996. The
Drosophila
rhom-
boid protein is concentrated in patches at the apical cell surface.
Dev Biol
174
(2):298-309.
50. Reich A, Sapir A, Shilo BZ. 1999. Sprouty, a general inhibitor of receptor tyrosine kinase
signaling.
Development
126
(18):413-447.
51. Deng WM, Bownes M. 1997. Two signalling pathways specify localised expression of the
Broad-Complex in
Drosophila
eggshell patterning and morphogenesis.
Development
124
(22):4639-4647.
52. Perrimon N, Duffy, JD. 1998. Developmental biology: sending all the right signals.
Nature
396
(6706):18-19.
53. Hinton HE. 1981,
Biology of insect eggs
, Vol. 1. Pergamon Press, New York.
54.
Dent P, Reardon D, Park J, Bowers G, Logsdon C, Valerie K, Schmidt-Ullrich R. 1999. Radia-
tion-induced release of transforming growth factor-
activates the epidermal growth factor re-
ceptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased
proliferation and protection from radiation-induced cell death.
Mol Biol Cell
10
:2493-2506.
55.
Lee H, R. Akita W, Sliwkowski MX, Maihle NJ. 2001. A naturally occurring secreted human
ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
Cancer Res
61
(11):4467-4473.
56.
Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman
DA, Podratz KC, Maihle NJ. 2003. Soluble epidermal growth factor receptor (sEGFR/sErbB1)
as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Cancer Epidemiol Biomarkers Prev
12
(2):103-13.
